ClinicalTrials.Veeva

Menu

Psychometric Properties of the Chinese Version of PeNAT

T

The Hong Kong Polytechnic University

Status

Not yet enrolling

Conditions

Vomiting
Nausea
Child
Cancer

Treatments

Other: PeNAT validation

Study type

Observational

Funder types

Other

Identifiers

NCT04827108
PeNAT validation

Details and patient eligibility

About

Cancer is a leading cause of death for children. Chemotherapy is the most common treatment for cancer. Notwithstanding the improved survival, children with cancer still have to face a significant amount of symptoms associated with chemotherapy. Two major symptoms induced by chemotherapy are nausea and vomiting. These two symptoms were demonstrated to cause serious disruption in patients' daily function and quality of life. Given these devastating impacts, intervening children with appropriate methods to alleviate nausea and vomiting during chemotherapy is therefore crucial. It is imperative for nurses to develop non-pharmacological interventions to reduce nausea and vomiting, with the goal of improving the QoL of children with cancer when undergoing chemotherapy First, however, careful assessment of nausea and vomiting in children with cancer is a necessary step towards designing appropriate interventions. This study aims to translate and validate an instrument (PeNAT) which can assess nausea and vomiting among Hong Kong Chinese children and adolescents undergoing chemotherapy

Full description

Currently, the most effective anti-emetics appear to be 5-HT3 inhibitors, followed by NK1 inhibitors and neuroleptic drugs. Nevertheless, anti-emetics alone are not sufficient to manage these two symptoms. This poor symptom control could be due to healthcare professionals' perception that nausea and vomiting are solely biological problems, and their heavy reliance on pharmacological treatment for management. After literature search, we can identify only one validated instrument, the Pediatric Nausea Assessment tool (PeNAT), assessing chemotherapy-induced nausea and vomiting in children. Yet, this instruments is not available in Chinese. This study aims to translate and validate an instrument (PeNAT) which can assess nausea and vomiting among Hong Kong Chinese children and adolescents undergoing chemotherapy

Enrollment

150 estimated patients

Sex

All

Ages

4 to 17 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Aged 4 - 17
  • A confirmed diagnosis of cancer
  • Currently undergoing chemotherapy
  • Able to speak Cantonese and read Chinese

Exclusion criteria

  • Cognitive or behavioral problems in medical records

Trial contacts and locations

0

Loading...

Central trial contact

Katherine Lam, PhD; Eva Ho, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems